Skip to main content
SpringerLink
Log in

Fecal calprotectin as a non-invasive marker for the prediction of post-necrotizing enterocolitis stricture

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Purpose

This study aimed to evaluate the clinical utility of fecal calprotectin (FC) levels during the necrotizing enterocolitis (NEC) episode to predict the onset of post-NEC intestinal stricture.

Methods

The medical records of patients with NEC treated from April 2020 to April 2022 were recorded for this study. FC was quantified at the acute phase of NEC. FC levels were compared in patients with or without intestinal stricture. Receiver operating characteristics (ROC) analysis was constructed to determine optimal cut-offs of FC for post-NEC intestinal stricture.

Results

A total of 50 infants with NEC were enrolled in this study and 14 (28%) of them eventually developed intestinal stricture. All children with intestinal stricture underwent one-stage surgery and all made it through the follow-up period alive. The median FC level was 1237.55 (741.25, 1378.80) ug/g in patients with intestinal stricture and it was significantly higher than that in the non-stricture group [158.30 (76.23, 349.13) ug/g, P < 0.001]. FC had good diagnostic accuracy for predicting intestinal stricture, according to ROC curve analysis, with an AUC area of 0.911. At an optimal cut-off value of 664.2 ug/g, sensitivity and specificity were 85.71% and 91.67%, respectively.

Conclusion

As a non-invasive parameter, FC has excellent efficacy and accuracy in predicting post-NEC intestinal stricture. Increased FC levels at the acute phase of NEC were associated with the development of intestinal stricture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The data supporting the findings of this study are available within the article, further inquiries can be directed to the corresponding author.

Abbreviations

NEC:

Necrotizing enterocolitis

FC:

Fecal calprotectin

ROC:

Receiver operating characteristics

PDA:

Patent Ductus Arteriosus

CRP:

C-reactive protein

PCT:

Procalcitonin

PLT:

Plateletcrit

WBC:

White blood cell

Hb:

Hemoglobin

References

  1. Nino DF, Sodhi CP, Hackam DJ (2016) Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol Hepatol 13(10):590–600

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Alganabi M, Lee C, Bindi E, Li B, Pierro A (2019) Recent advances in understanding necrotizing enterocolitis. F1000Res 8:107

    Article  CAS  Google Scholar 

  3. Hartman GE, Drugas GT, Shochat SJ (1988) Post-necrotizing enterocolitis strictures presenting with sepsis or perforation: risk of clinical observation. J Pediatr Surg 23(6):562–566

    Article  CAS  PubMed  Google Scholar 

  4. Jukic A, Bakiri L, Wagner EF, Tilg H, Adolph TE (2021) Calprotectin: from biomarker to biological function. Gut 70(10):1978–1988

    Article  CAS  PubMed  Google Scholar 

  5. Terrin G, Passariello A, De Curtis M, Paludetto R, Berni CR (2012) S100 A8/A9 protein as a marker for early diagnosis of necrotising enterocolitis in neonates. Arch Dis Child 97(12):1102

    Article  PubMed  Google Scholar 

  6. Campeotto F, Kalach N, Lapillonne A, Butel MJ, Dupont C, Kapel N (2007) Time course of faecal calprotectin in preterm newborns during the first month of life. Acta Paediatr 96(10):1531–1533

    Article  PubMed  Google Scholar 

  7. Reisinger KW, Van der Zee DC, Brouwers HA, Kramer BW, van Heurn LW, Buurman WA et al (2012) Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg 47(9):1640–1645

    Article  PubMed  Google Scholar 

  8. Phad N, Trivedi A, Todd D, Lakkundi A (2014) Intestinal strictures post-necrotising enterocolitis: clinical profile and risk factors. J Neonatal Surg 3(4):44

    Article  PubMed  PubMed Central  Google Scholar 

  9. Walsh MC, Kliegman RM (1986) Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 33(1):179–201

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Houben CH, Chan KW, Mou JW, Tam YH, Lee KH (2016) Management of intestinal strictures post conservative treatment of necrotizing enterocolitis: the long term outcome. J Neonatal Surg 5(3):28

    Article  PubMed  PubMed Central  Google Scholar 

  11. Heida FH, Loos MH, Stolwijk L, Te Kiefte BJ, van den Ende SJ, Onland W et al (2016) Risk factors associated with postnecrotizing enterocolitis strictures in infants. J Pediatr Surg 51(7):1126–1130

    Article  CAS  PubMed  Google Scholar 

  12. Gaudin A, Farnoux C, Bonnard A, Alison M, Maury L, Biran V et al (2013) Necrotizing enterocolitis (NEC) and the risk of intestinal stricture: the value of C-reactive protein. PLoS One 8(10):e76858

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Schimpl G, Hollwarth ME, Fotter R, Becker H (1994) Late intestinal strictures following successful treatment of necrotizing enterocolitis. Acta Paediatr Suppl 396:80–83

    Article  CAS  PubMed  Google Scholar 

  14. Liu W, Wang Y, Zhu J, Zhang C, Liu G, Wang X et al (2020) Clinical features and management of post-necrotizing enterocolitis strictures in infants: a multicentre retrospective study. Medicine (Baltimore) 99(19):e20209

    Article  PubMed  Google Scholar 

  15. Burnand KM, Zaparackaite I, Lahiri RP, Parsons G, Farrugia MK, Clarke SA et al (2016) The value of contrast studies in the evaluation of bowel strictures after necrotising enterocolitis. Pediatr Surg Int 32(5):465–470

    Article  PubMed  Google Scholar 

  16. Zhang H, Chen J, Wang Y, Deng C, Li L, Guo C (2017) Predictive factors and clinical practice profile for strictures post-necrotising enterocolitis. Medicine (Baltimore) 96(10):e6273

    Article  PubMed  Google Scholar 

  17. Imai J, Hozumi K, Sumiyoshi H, Yazawa M, Hirano K, Abe J et al (2015) Anti-fibrotic effects of a novel small compound on the regulation of cytokine production in a mouse model of colorectal fibrosis. Biochem Biophys Res Commun 468(4):554–560

    Article  CAS  PubMed  Google Scholar 

  18. Aydemir G, Cekmez F, Tanju IA, Canpolat FE, Genc FA, Yildirim S et al (2012) Increased fecal calprotectin in preterm infants with necrotizing enterocolitis. Clin Lab 58(7–8):841–844

    CAS  PubMed  Google Scholar 

  19. Yoon JM, Park JY, Ko KO, Lim JW, Cheon EJ, Kim HJ (2014) Fecal calprotectin concentration in neonatal necrotizing enterocolitis. Korean J Pediatr 57(8):351–356

    Article  PubMed  PubMed Central  Google Scholar 

  20. Olafsdottir E, Aksnes L, Fluge G, Berstad A (2002) Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 91(1):45–50

    Article  CAS  PubMed  Google Scholar 

  21. Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F et al (2004) Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis 36(7):467–70

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors have no support or funding to report.

Author information

Author notes

  1. Guanglin Chen and Xiaofeng Lv have contributed equally to this work.

Authors and Affiliations

  1. Department of Pediatric Surgery, Children’s Hospital of Nanjing Medical University, Nanjing, 210008, China

    Guanglin Chen, Xiaofeng Lv & Weibing Tang

Authors
  1. Guanglin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaofeng Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Weibing Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Data acquisition and analysis: XL; Drafting of the manuscript: GC; Critical revision: WT. All authors reviewed the manuscript.

Corresponding author

Correspondence to Weibing Tang.

Ethics declarations

Conflict of interest

The authors have declared that no competing interest exists.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, G., Lv, X. & Tang, W. Fecal calprotectin as a non-invasive marker for the prediction of post-necrotizing enterocolitis stricture. Pediatr Surg Int 39, 250 (2023). https://doi.org/10.1007/s00383-023-05534-7

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00383-023-05534-7

Keywords

Search

Navigation